143 related articles for article (PubMed ID: 35440336)
1. A Clinically Validated, Broadly Active, Oral Viral Superinfection Therapy Could Mitigate Symptoms in Early-stage COVID-19 Patients.
Bakacs T; Sandig V; Slavin S; Gumrukcu S; Hardy D; Renz W; Kovesdi I
Infect Disord Drug Targets; 2022; 22(7):1-6. PubMed ID: 35440336
[TBL] [Abstract][Full Text] [Related]
2. An Orally Administered Nonpathogenic Attenuated Vaccine Virus Can Be Used to Control SARS-CoV-2 Infection: A Complementary Plan B to COVID-19 Vaccination.
Bakacs T; Sandig V; Kovesdi I
Cureus; 2022 Aug; 14(8):e28467. PubMed ID: 36176842
[TBL] [Abstract][Full Text] [Related]
3. Combination Therapy for the Treatment of Shingles with an Immunostimulatory Vaccine Virus and Acyclovir.
Bakacs T; Sandig V; Kovesdi I
Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259374
[TBL] [Abstract][Full Text] [Related]
4. Effective multiple oral administration of reverse genetics engineered infectious bursal disease virus in mice in the presence of neutralizing antibodies.
Hornyák Á; Lipinski KS; Bakonyi T; Forgách P; Horváth E; Farsang A; Hedley SJ; Palya V; Bakács T; Kovesdi I
J Gene Med; 2015; 17(6-7):116-31. PubMed ID: 25929556
[TBL] [Abstract][Full Text] [Related]
5. Healing of Severe Herpes Zoster Ophthalmicus Within a Few Days: An Autobiographical Case Report.
Bakacs T
Cureus; 2021 Dec; 13(12):e20303. PubMed ID: 35024256
[TBL] [Abstract][Full Text] [Related]
6. Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs.
Bakacs T; Safadi R; Kovesdi I
Hepatol Med Policy; 2018; 3():2. PubMed ID: 30288325
[TBL] [Abstract][Full Text] [Related]
7. Exacerbated Apoptosis of Cells Infected with Infectious Bursal Disease Virus upon Exposure to Interferon Alpha.
Cubas-Gaona LL; Diaz-Beneitez E; Ciscar M; Rodríguez JF; Rodríguez D
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540594
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Exploitation of Viral Interference.
Kovesdi I; Bakacs T
Infect Disord Drug Targets; 2020; 20(4):423-432. PubMed ID: 30950360
[TBL] [Abstract][Full Text] [Related]
9. Sequential Combination of a Strong Interferon Inducer Viral Vector With Low Doses of Nivolumab Plus Ipilimumab Could Provide Functional Cure in Chronic Hepatitis B Virus infections: Technical Report Proposing a New Modality.
Bakacs T; Safadi R; Puskás LG; Fehér LZ; Kovesdi I
Cureus; 2022 Mar; 14(3):e22750. PubMed ID: 35371882
[TBL] [Abstract][Full Text] [Related]
10. VP1 and VP3 Are Required and Sufficient for Translation Initiation of Uncapped Infectious Bursal Disease Virus Genomic Double-Stranded RNA.
Ye C; Wang Y; Zhang E; Han X; Yu Z; Liu H
J Virol; 2018 Jan; 92(2):. PubMed ID: 29093101
[TBL] [Abstract][Full Text] [Related]
11. STAU1 binds to IBDV genomic double-stranded RNA and promotes viral replication via attenuation of MDA5-dependent β interferon induction.
Ye C; Yu Z; Xiong Y; Wang Y; Ruan Y; Guo Y; Chen M; Luan S; Zhang E; Liu H
FASEB J; 2019 Jan; 33(1):286-300. PubMed ID: 29979632
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylinositol 3-Phosphate Mediates the Establishment of Infectious Bursal Disease Virus Replication Complexes in Association with Early Endosomes.
Gimenez MC; Issa M; Sheth J; Colombo MI; Terebiznik MR; Delgui LR
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361427
[No Abstract] [Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
15. The RNA-Binding Protein of a Double-Stranded RNA Virus Acts like a Scaffold Protein.
Mata CP; Mertens J; Fontana J; Luque D; Allende-Ballestero C; Reguera D; Trus BL; Steven AC; Carrascosa JL; Castón JR
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021893
[TBL] [Abstract][Full Text] [Related]
16. Infectious Bursal Disease Virus Hijacks Endosomal Membranes as the Scaffolding Structure for Viral Replication.
Gimenez MC; Zanetti FA; Terebiznik MR; Colombo MI; Delgui LR
J Virol; 2018 Jun; 92(11):. PubMed ID: 29540593
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of antiviral innate immunity by birnavirus VP3 protein via blockage of viral double-stranded RNA binding to the host cytoplasmic RNA detector MDA5.
Ye C; Jia L; Sun Y; Hu B; Wang L; Lu X; Zhou J
J Virol; 2014 Oct; 88(19):11154-65. PubMed ID: 25031338
[TBL] [Abstract][Full Text] [Related]
18. GATA3 Inhibits Viral Infection by Promoting MicroRNA-155 Expression.
Li J; Haiyilati A; Zhou L; Chen J; Wang Y; Gao L; Cao H; Li X; Zheng SJ
J Virol; 2022 Apr; 96(7):e0188821. PubMed ID: 35319228
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Immunosuppression of Avian Leukosis Virus Subgroup J and Infectious Bursal Disease Virus Is Responsible for Enhanced Pathogenicity.
Chen W; Chen S; Nie Y; Li W; Li H; Zhang X; Chen F; Xie Q
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298866
[TBL] [Abstract][Full Text] [Related]
20. Infectious Bursal Disease Virus Subverts Autophagic Vacuoles To Promote Viral Maturation and Release.
Wang Y; Duan Y; Han C; Yao S; Qi X; Gao Y; Maier HJ; Britton P; Chen L; Zhang L; Gao L; Gao H; Shen N; Wang J; Wang X
J Virol; 2017 Mar; 91(5):. PubMed ID: 27974565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
